Association of Toll like receptor Asp299Gly with rheumatoid arthritis risk: A systematic review of case-control studies and meta-analysis

Pathology Research and Practice

Volumn 211, Issue 3, 2015, Pages 219-225

  Tizaoui, Kalthoum ^a   Naouali, Abir ^a   Kaabachi, Wajih ^a   Hamzaoui, Agnès ^a,b   Hamzaoui, Kamel ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

Author keywords

Meta analysis; Rheumatoid arthritis; SNPs; TLR genes; TLR4 Asp299Gly

Indexed keywords

ASPARTIC ACID; GLYCINE; TOLL LIKE RECEPTOR;

ALLELE; ARTICLE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; PATHOGENESIS; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; TOLL LIKE RECEPTOR GENE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARTHRITIS, RHEUMATOID; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTORS;

EID: 84940164064     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.11.001     Document Type: Article

References (53)

1. Cutolo M., Otsa K., Paolino S., Yprus M., Veldi T., Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis. 2009, 68:446-447.
2. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011, 365:23.
3. Bax M., van Heemst J., Huizinga T.W., Toes R.E. Genetics of rheumatoid arthritis: what have we learned?. Immunogenetics 2011, 63:459-466.
4. Chatzikyriakidou A., Voulgari P.V., Lambropoulos A., Drosos A.A. Genetics in rheumatoid arthritis beyond HLA genes: what meta-analyses have shown?. Semin. Arthritis Rheum. 2013, 43:29-38.
5. Sambroook P.N. The skeleton in rheumatoid arthritis: common mechanisms for bone. J. Rheumatol. 2000, 27:2541-2542.
6. Annunziato F., Cosmi L., Liotta F., et al. Type 17T helper cells-origins, features and possible roles in rheumatic disease. Nat. Rev. Rheumatol. 2009, 5:325-331.
7. Roelofs M.F., Joosten L.A.B., Abdollahi-Roodsaz S., van Lieshout A.W.T., Sprong T., van den Hoogen F.H., van den Berg W.B., Radstake T.R.D.J. The expression of Toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of Toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum. 2005, 52:2313-2322.
8. Kuuliala K., Orpana A., Leirisalo-Repo M., Kautiainen H., Hurme M., Hannonen P., Korpela M., Mottonen T., Paimela L., Puolakka K., Karjalainen A., Repo H. Polymorphism at position +896 of the toll-like receptor 4 gene interferes with rapid response to treatment in rheumatoid arthritis. Ann. Rheum. Dis. 2006, 65:1241-1243.
9. Ospelt C., Brentano F., Rengel Y., Stanczyk J., Kolling C., Tak P.P., Gay R.E., Gay S., Kyburz D. Overexpression of Toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis. Toll-like receptor expression in early and longstanding arthritis. Arthritis Rheum. 2008, 58:3684-3692.
10. Akira S., Takeda K. Toll-like receptor signaling. Nat. Rev. Immunol. 2004, 4:499-511.
11. Kang S.S., Kauls L.S., Gaspari A.A. Toll-like receptors: applications to dermatologic disease. J. Am. Acad. Dermatol. 2006, 54:951-983.
12. Shin H.S., Jung Y.S., Rim H. Toll-like receptors. Br. J. Med. Med. Res. 2013, 3:58-68.
13. Brentano F., Kyburz D., Schorr O., Gay R., Gay S. The role of Toll-like receptor signalling in the pathogenesis of arthritis. Cell. Immunol. 2005, 233:90-96.
14. Kaneko S., Suzuki N., Yamashita N., et al. Characterization of T cells specific for an epitope of human 60-kDa heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin. Exp. Immunol. 1997, 108:204-212.
15. Roelofs M.F., Abdollahi-Roodsaz S., Joosten L.A., Van Denberg W.B., Radastake T.R. The orchestra of Toll-like receptors and their potential role in frequently occurring rheumatic conditions. Arthritis Rheum. 2008, 58:338-348.
16. Noreen M., Shah M.A., Mall S.M., Choudhary S., Hussain T., Ahmed I., Jalil S.F., Raza M.I. TLR4 polymorphisms and disease susceptibility. Inflamm. Res. 2012, 61:177-188.
17. Auger I., Roudier J. A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK: implications for the association of rheumatoid arthritis with HLA-DR4. J. Clin. Invest. 1997, 99:1818-1822.
18. Kamphuis S., Kuis W., de Jager W., et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 2005, 366:50-56.
19. Radstake T.R., Franke B., Hanssen S., Netea M.G., Welsing P., Barrera P., Joosten L.A., van Riel P.L., Berg van den W.B. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum. 2004, 50:999-1001.
20. Lee E.Y., Yim J.J., Lee H.S., Lee Y.J., Lee E.B., Song Y.W. Dinucleotide repeat polymorphism in intron II of human Toll-like receptor 2 gene and susceptibility to rheumatoid arthritis. Int. J. Immunogenet. 2006, 33:211-215.
21. Etem E.O., Elyas H., Ozgocmen S., Yildirim A., Godekmerdan A. The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol. Int. 2011, 31:1369-1374.
22. Yang H.C., Wei G., Li Q., Shou T., Yang Y., Xiao C., et al. Association of TLR4 gene non-missense single nucleotide polymorphisms with rheumatoid arthritis in Chinese Han population. Rheumatol. Int. 2013, 33:1283-1288.
23. Enevold C., Radstake T.R., Coenen M.J., Fransen J., Toonen E.J., et al. Multiplex screening of 22 single-nucleotide polymorphisms in 7 Toll-like receptors: an association study in rheumatoid arthritis. J. Rheumatol. 2010, 37:905-910.
24. Kilding R., Akil M., Till S., Amos R., Winfield J., Iles M.M., Wilson A.G. A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin. Exp. Rheumatol. 2003, 21:340-342.
25. Sanchez E., Orozco G., Lopez-Nevot M.A., Jimenez-Alonso J., Martin J. Polymorphisms of toll-like receptor 2 and 4 genes in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2004, 63:54-57.
26. Sheedy F.J., Marinou I., O'Neill L.A., Wilson A.G. The Mal/TIRAP S180L and TLR4 G299D polymorphisms are not associated with susceptibility to, or severity of, rheumatoid arthritis. Ann. Rheum. Dis. 2008, 67:1328-1331.
27. Orozco G., Morales S., González-Gay M.Á., González Rugeles C.I., Ramírez Quintero G., Martín J. Toll-like receptor 4 Asp299Gly polymorphism and rheumatoid arthritis: a replicative study in three different populations. Inmunología 2005, 24:205-207.
28. Kang E.S., Lee J. Genotypic analysis of Asp299Gly and Thr399Ile polymorphism of Toll-like receptor 4 in systemic autoimmune diseases of Korean population. Rheumatol. Int. 2007, 27:887-889.
29. Jaen O., Petit-Teixeira E., Kirsten H., Ahnert P., Semerano L., Pierlot C., Cornelis F., Boissier M.C., Falgarone G. No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res. Ther. 2009, 1:R5.
30. Zheng B., Li Q., Wei C., Qin J., Shou T., Zhou R., et al. Lack of association of TLR4 gene Asp299Gly and Thr399Il e polymorphisms with rheumatoid arthritis in Chinese Han population of Yunnan Province. Rheumatol. Int. 2010, 30:1249-1252.
31. Alvarez-Rodriguez L., Lopez-Hoyos M., Beares I., Mata C., Garcia-Unzueta M., Calvo-Alen J., Blanco R., Aurrecoechea E., Tripathi G., Martinez-Taboada V.M. Toll-like receptor 4 gene polymorphisms in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Clin. Exp. Rheumatol. 2011, 29:795-800.
32. Dhaouadi T., Sfar I., Haouami Y., Abdelmoula L., Turki S., Ben Hassine L., Zouari R., Khedher A., Khalfallah N., Ben Abdallah T., Gorgi Y. Polymorphisms of Toll-like receptor-4 and CD14 in systemic lupus erythematosus and rheumatoid arthritis. Biomark. Res. 2013, 1:20.
33. Emonts M., Hazes M.J., Houwing-Duistermaat J.J., et al. Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study. BMC Med. Genet. 2011, 12:36.
34. Coenen M.J.H., Enevold C., Barrera P., Mascha M.V., Schijvenaars A.P., Toonen E.J.M., et al. Genetic variants in Toll-like receptors are not associated with rheumatoid arthritis susceptibility or anti-tumour necrosis factor treatment outcome. PLoS ONE 2010, 5(12). e14326.
35. Xu W.D., Liu S.S., Pan H.F., Ye D.Q. Lack of association of TLR4 polymorphisms with susceptibility to rheumatoid arthritis and ankylosing spondylitis: a meta-analysis. Joint Bone Spine 2012, 79:566-569.
36. Lee Y.H., Bae S.C., Song G.G. Meta-analysis demonstrates association between TLR polymorphisms and rheumatoid arthritis. Genet. Mol. Res. 2013, 12:328-334.
37. Lee Y.H., Bae S.-C., Kim J.-H., Song G.G. Toll-like receptor polymorphisms and rheumatoid arthritis: a systematic review. Rheumatol. Int. 2014, 34:111-116.
38. Moher D., Liberati A., Tetzlaff J., Altman D.G. The PRISMA Group: preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009, 6(7):e1000097.
39. Light R.J., Singer R.J.D., Willett J.B. The visual presentation and interpretation of meta-analysis. The Handbook of Research Synthesis 1994, 439-454. Russell Sage Foundation, New York. H. Cooper, L.V. Hedges (Eds.).
40. Thakkinstian A., Mcelduff P., D'Este C., Duffy D., Attia J. A method for meta-analysis of molecular association studies. Stat. Med. 2005, 24:1291-1306.
41. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
42. Kavvoura F.K., Ioannidis J.P.A. Methods for meta-analysis in genetic association studies: a review of their potential and pitfalls. Hum. Genet. 2008, 123:1-14.
43. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:624-634.
44. Arnett F.C., Edworthy S.M., Bloch D.A., Mcshane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315-324.
45. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
46. Drexler S.K., Foxwell B.M. The role of toll-like receptors in chronic inflammation. Int. J. Biochem. Cell Biol. 2010, 42:506-518.
47. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9362-9367.
48. Netea M.G., Wijmenga C., O'Neill L.A.J. Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol. 2012, 13:535-542.
49. Shigeoka A.A., Kambo A., Mathison J.C., et al. NOD1 and NOD2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J. Immunol. 2010, 184:2297-2304.
50. Fukata M., Vamadevan A.S., Abreu M.T. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin. Immunol. 2009, 21:242-253.
51. Yoneyama M., Kikkuchi M., Natsukwa T., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA induced innate antiviral responses. Nat. Immunol. 2004, 5:730-737.
52. Little J., Higgins J.P., Ionnidis J.P., et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Hum. Genet. 2009, 125:131-151.
53. Jing L., Wang X., Zhang F., Yin H. Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases. Pharmacol. Ther. 2013, 138:441-451.